Widening for clopidogrel BE study [Outliers]

posted by mittyri – Russia, 2021-06-16 16:04 (40 d 08:54 ago) – Posting: # 22419
Views: 643

Dear Loky do

» is widening of Cmax accepted in clopidogrel BE studies with fully replicate design or not?

You linked the EMA Q&A where it is stated unequivocally:
Under these circumstances, the widening of 90% confidence intervals for Cmax is not recommended.

Kind regards,
Mittyri

Complete thread:

Activity
 Admin contact
21,589 posts in 4,512 threads, 1,530 registered users;
online 6 (0 registered, 6 guests [including 4 identified bots]).
Forum time: Tuesday 00:59 CEST (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5